On our screens:Stocks with no debtCheap stocks by free cash flow yieldQuality compoundersQuality at a reasonable price
The financials
Nutex Health Inc. by the numbers
Nutex Health Inc. (NUTX) reported revenue of $216M in Q1 2026 (quarter ended Mar 31, 2026), up 2.2% from the same quarter a year earlier. That came with a gross margin of 42% and net income of $47M (22% of revenue). For the full year FY2025, revenue was $875M (+82% year on year) and net income $71M. Its largest product in Jun 2026 was Hospital Division at $202M, 96% of the disclosed total, well ahead of Population Health Management Division at 4.2%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $216M | $212M | +2.2% |
| Gross profit | $92M | $118M | −22% |
| Operating income | $81M | $81M | +0.7% |
| Net income | $47M | $21M | +121% |
| Diluted EPS | $6.52 | $3.33 | +96% |
| Product | Revenue | Share |
|---|---|---|
| Hospital Division | $202M | 96% |
| Population Health Management Division | $8.9M | 4.2% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $210.8M (-2.6%)
Population Health Management Division grew +16% year on yearHospital Division -15% year on year
Segment Latestquarter on quarteryear on year
- Hospital Division$201.9M$201.9MQoQ -2.8%year on year -15%-2.8%-15%
- Population Health Management Division$8.9M$8.9MQoQ -0.17%year on year +16%-0.17%+16%